FY 2023 DOE Metrics
Sequencing
| Quarter | Total Bases (Trillions) | Operating Hours | ||||
|---|---|---|---|---|---|---|
| Goal | Actual Total* | Actual % of Goal | Goal (hours)** | Actual Total | Actual % Goal | |
| Q1 2023 | 150.0 | 170.477 | 114% | 2,164 | 2,112 | 98% |
| Q2 2023 | 150.0 | 173.492 | 116% | 2,117 | 2,160 | 102% |
| Q3 2023 | 150.0 | 155.721 | 104% | 2,140 | 2,184 | 102% |
| Q4 2023 | 150.0 | 2,164 | ||||
| FY 2023 Total | 600.0 | 8,585 | ||||
*Includes Illumina and PacBio sequencing platforms.
**Operating Hours target is based on 98% of the total available hours.
FY 2022 DOE Metrics
There were 2,243 unique* JGI users in FY2021, which includes Principal Investigators (PIs), Co-PIs, and collaborators.
*Unique users are counted once, even though an individual may have several projects/roles.
Sequencing
| Quarter | Total Bases (Trillions) | Operating Hours | ||||
|---|---|---|---|---|---|---|
| Goal | Actual Total* | Actual % of Goal | Goal (hours)** | Actual Total | Actual % Goal | |
| Q1 2022 | 87.500 | 151.270 | 173% | 2,164 | 2,184 | 100.9% |
| Q2 2022 | 87.500 | 159.116 | 182% | 2,117 | 2,160 | 102.0% |
| Q3 2022 | 87.500 | 167.731 | 191% | 2,140 | 2,184 | 102.1% |
| Q4 2022 | 87.500 | 180.078 | 206% | 2,164 | 2,208 | 102.0% |
| FY 2022 Total | 350.0 | 658.195 | 188% | 8,585 | 8,736 | 101.8% |
*Includes Illumina and PacBio sequencing platforms.
**Operating Hours target is based on 98% of the total available hours.
FY 2021 DOE Metrics
There were 2,180 unique* JGI users in FY2021, which includes Principal Investigators (PIs), Co-PIs, and collaborators.
*Unique users are counted once, even though an individual may have several projects/roles.
Sequencing
| Quarter | Total Bases (Trillions) | Operating Hours | ||||
|---|---|---|---|---|---|---|
| Goal | Actual Total* | Actual % of Goal | Goal (hours)** | Actual Total | Actual % Goal | |
| Q1 2021 | 62.500 | 112.109 | 179% | 2,164 | 2,112 | 97.6% |
| Q2 2021 | 62.500 | 108.312 | 173% | 2,117 | 2,064 | 97.5% |
| Q3 2021 | 62.500 | 127.333 | 204% | 2,140 | 2,184 | 102.1% |
| Q4 2021 | 62.500 | 119.441 | 191% | 2,164 | 2,208 | 102.1% |
| FY 2021 Total | 250.0 | 467.195 | 187% | 8,760 | 8,568 | 99.8% |
*Includes Illumina and PacBio sequencing platforms.
**Operating Hours target is based on 98% of the total available hours.
FY 2020 DOE Metrics
There were 2,038 unique* JGI users in FY2020, which includes Principal Investigators (PIs), Co-PIs, and collaborators.
*Unique users are counted once, even though an individual may have several projects/roles.
Sequencing
| Quarter | Total Bases (Trillions) | Operating Hours | ||||
|---|---|---|---|---|---|---|
| Goal | Actual Total* | Actual % of Goal | Goal (hours)** | Actual Total | Actual % Goal | |
| Q1 2020 | 37.000 | 67.184 | 182% | 1,488 | 1,560 | 104.8% |
| Q2 2020 | 71.000 | 71.189 | 100.% | 2,140 | 1,824 | 85.2%† |
| Q3 2020 | 71.000 | 28.127 | 40% | 2,140 | 576 | 26.9%†† |
| Q4 2020 | 71.000 | 123.993 | 175% | 2,164 | 1,656 | 76.5% ††† |
| FY 2020 Total | 250.0 | 290.492 | 116% | 7,932 | 5,616 | 70.8% |
† Operational Goal = 89 days; Actual Operation = 76 days due to shelter in place order.
†† Operation Goal = 91 days; Actual Operation = 24 days due to significant sequencer downtime related to the shelter-in-place.
††† Actual Operation = 69 days due to reduced lab activities related to the return-to-work plan in response to the pandemic.
FY 2019 Number of Unique Users
There were 1,933 unique* JGI users in FY2019, which includes Principal Investigators (PIs), Co-PIs, and collaborators.
*Unique users are counted once, even though an individual may have several projects/roles.
Sequencing
| Quarter | Total Bases (Trillions) | Operating Hours | ||||
|---|---|---|---|---|---|---|
| Goal | Actual Total* | Actual % of Goal | Goal (hours)** | Actual Total | Actual % Goal | |
| Q1 2019 | 60.5 | 75,222 | 124.3% | 2,164 | 2,160 | 99.8% |
| Q2 2019 | 60.5 | 73,329 | 121.2% | 2,117 | 2,160 | 102.0% |
| Q3 2019 | 60.5 | 85,174 | 141.1% | 2,140 | 2,184 | 102.1% |
| Q4 2019 | 60.5 | 92,765 | 153.3% | 2,164 | 2,208 | 102.0% |
| FY 2019 Total | 242.0 | 326.490 | 134.9% | 8,584 | 8,712 | 101.5% |
*Includes Illumina NovaSeq, Illumina NextSeq, Illumina MiSeq, and PacBio sequencing platforms.
**Operating Hour target is based on 98% of the total available hours.
FY 2018 Number of Unique Users
There were 1,882 unique* JGI users in FY2018, which includes Principal Investigators (PIs), Co-PIs, and collaborators.
*Unique users are counted once, even though an individual may have several projects/roles.
FY 2018 DOE Metrics
Sequencing
| Quarter | Total Bases (Billions) | Operating Hours | ||||
|---|---|---|---|---|---|---|
| Goal | Actual Total* | Actual % of Goal | Goal (hours)** | Actual Total | Actual % Goal | |
| Q1 2018 | 40,000 | 41,251 | 103.1% | 2,164 | 2,160 | 99.8% |
| Q2 2018 | 48,000 | 52,966 | 110.3% | 2,117 | 2,136 | 100.9% |
| Q3 2018 | 54,000 | 61,176 | 113.3% | 2,140 | 2,184 | 102.1% |
| Q4 2018 | 58,000 | 69,906 | 120.5% | 2,164 | 2,208 | 102.0% |
| FY 2018 Total | 200,000 | 225,299 | 112.6% | 8,584 | 8,688 | 101.2% |
*Includes Illumina HiSeq, Illumina NextSeq, Illumina Miseq and PacBio Sequencing platforms.
**Operating Hour target is based on 98% of the total available hours.
FY 2017 DOE Metrics
1,598 unique* JGI users in FY2017
Sequencing
| Quarter | Total Bases (Billions) | Operating Hours | ||||
|---|---|---|---|---|---|---|
| Goal | Actual Total* | Actual % of Goal | Goal (hours)** | Actual Total | Actual % Goal | |
| Q1 2017 | 37,500 | 40,942 | 109% | 2,164 | 2,208 | 102% |
| Q2 2017 | 37,500 | 32, 178 | 86% | 2,117 | 2,160 | 102% |
| Q3 2017 | 37,500 | 57,515 | 153% | 2,140 | 2,184 | 102% |
| Q4 2017 | 37,500 | 47,501 | 127% | 2,164 | 2,208 | 102% |
| FY 2017 Total | 150,000 | 178,144 | 119% | 8,584 | 8,760 | 102% |
*Includes Illumina HiSeq, Illumina NextSeq, Illumina Miseq and PacBio Sequencing platforms.
**Operating Hour target is based on 98% of the total available hours.
FY 2016 DOE Metrics
1,391 unique* JGI users in FY2016
Sequencing
| Quarter | Total Bases (Billions) | Operating Hours | ||||
|---|---|---|---|---|---|---|
| Goal | Actual Total** | Actual % of Goal | Goal (hours)*** | Actual Total | Actual % Goal | |
| Q1 2016 | 34,000 | 28,574 | 84.0% | 2,164 | 2,160 | 99.8% |
| Q2 2016 | 35,000 | 31,643 | 90.4% | 2,140 | 2,136 | 99.8% |
| Q3 2016* | 35,000 | 44,580 | 127.4% | 2,140 | 2,184 | 102.1% |
| Q4 2016 | 20,000 | 37,073 | 185.4% | 2,164 | 2,208 | 102.0% |
| FY 2016 Total | 124,000 | 141,871 | 114.4% | 8,608 | 8,688 | 100.9% |
*Anticipated 50% reduced capacity for Q3 due to Clarity LIMS transition.
**Includes Illumina HiSeq, Illumina NextSeq, Illumina Miseq and PacBio Sequencing platforms.
***Operating Hour target is based on 98% of the total available hours.
FY 2015 Number of Unique Users
There were 958 unique* JGI users in FY2015, which includes Principal Investigators (PIs), Co-PIs, and collaborators.
*Unique users are counted once, even though an individual may have several projects/roles.
FY 2015 DOE Metrics
Sequencing
| Quarter | Total Bases (Billions) | Operating Hours | ||||
|---|---|---|---|---|---|---|
| Goal | Actual Total* | Actual % of Goal | Goal (hours)** | Actual Total | Actual % Goal | |
| Q1 2015 | 24,500 | 29,857 | 122% | 2,164 | 2,208 | 102% |
| Q2 2015 | 28,500 | 34,953 | 123% | 2,117 | 2,160 | 102% |
| Q3 2015 | 28,500 | 41,036 | 144% | 2,140 | 2,184 | 102% |
| Q4 2015 | 28,500 | 37,331 | 131% | 2,164 | 2,208 | 102% |
| FY 2015 Total | 110,000 | 143,177 | 130% | 8,585 | 8,760 | 102% |
* Includes Illumina HiSeq, MiSeq and PacBio sequencing platforms.
** Operating Hour target is based on 98% of the total available hours.
Other DOE Quarterly Metrics
Q1 – Report on new computational developments for improving microbial, metagenomic, or plant genome assemblies. [Download PDF]
Q2 – Report on progress developing new experimental capabilities to analyze complex genomic or metagenomic datasets. [Download PDF]
Q3 – Report on new computational approaches for the annotation of genomic data. [Download PDF]
Q4 – Report on a new computational method for improving the interpretation of microbial, metagenomic, or plant genomes. [Download PDF]
End-of-year Goal – Develop one new computationally enabled approach to analyze complex genomic datasets. [Download PDF]
FY 2014 Overall Sequencing Progress, Updated Quarterly
| Quarter | Total Bases (Billions) | Operating Hours | ||||
|---|---|---|---|---|---|---|
| Goal | Actual Total* | Actual % of Goal | Goal (hours)** | Actual Total | Actual % Goal | |
| Q1 2014 | 15,000 | 18,827 | 126% | 2,164 | 2,208 | 102% |
| Q2 2014 | 17,000 | 19,149 | 113% | 2,117 | 2,160 | 102% |
| Q3 2014 | 18,000 | 24,309 | 135% | 2,140 | 2,184 | 102% |
| Q4 2014 | 18,000 | 38,323 | 213% | 2,164 | 2,208 | 102% |
| FY 2014 Total | 68,000 | 100,608 | 148% | 8,585 | 8,760 | 102% |
* Includes Illumina HiSeq, MiSeq and PacBio sequencing platforms.
** Operating Hour target is based on 98% of the total available hours.
FY 2013 Overall Sequencing Progress, Updated Quarterly
| Quarter | Total Bases (Billions) | Operating Hours | ||||
|---|---|---|---|---|---|---|
| Goal | Actual Total* | Actual % of Goal | Goal (hours)** | Actual Total | Actual % Goal | |
| Q1 2013 | 15,000 | 20,004 | 133% | 2,164 | 2,208 | 102% |
| Q2 2013 | 15,000 | 18,882 | 126% | 2,117 | 2,160 | 102% |
| Q3 2013 | 18,000 | 13,904 | 77% | 2,140 | 2,184 | 102% |
| Q4 2013 | 18,000 | 18,073 | 100% | 2,164 | 2,208 | 102% |
| FY 2013 Total | 66,000 | 70,863 | 107% | 8,585 | 8,760 | 102% |
* Includes Illumina HiSeq, MiSeq and PacBio sequencing platforms.
** Operating Hour target is based on 98% of the total available hours.
FY 2012 Overall Sequencing Progress, Updated Quarterly
| Quarter | Total Bases (Billions) | Operating Hours | ||||
|---|---|---|---|---|---|---|
| Goal | Actual Total | Actual % of Goal | Goal (hours)* | Actual Total | Actual % Goal | |
| Q1 2012 | 10,000 | 12,923 | 129% | 2,164 | 2,208 | 102% |
| Q2 2012 | 7,000 | 17,280 | 247% | 1,848 | 2,184 | 118% |
| Q3 2012 | 13,755 | 15,099 | 110% | 2,140 | 1,944 | 91% |
| Q4 2012 | 14,100 | 10,813 | 77% | 2,164 | 2,208 | 102% |
| FY 2012 Total | 44,855 | 56,115 | 125% | 8,316 | 8,544 | 103% |
* Operating Hour target is based on 98% of the total available hours. Reduced operating hour target in Q2 is due to planned upgrade of the Laboratory Information Management System (LIMS) and temporary shut down of the sequencing production line to accommodate data migration requirements. Q3 actual Operating Hours reflect a delay in implementation of the LIMS from Q2 to Q3. As a result of the delay in the LIMS implementation, the Q4 base total is below target.
FY 2011 Summary
| Quarter | Total Bases (Billions) | Total Bases (Billions) by Platform | Operating Hours* | |||||
|---|---|---|---|---|---|---|---|---|
| Goal | Actual Total | Actual % of Goal | 454 | Illumina | Goal (hours) | Actual Total | Actual % Goal | |
| Q1 2011 | 1,500 | 3,233.30 | 216 | 73.27 | 3,160.03 | 2100 | 2208 | 105 |
| Q2 2011 | 3,000 | 4,999.74 | 167 | 43.14 | 4,956.60 | 2100 | 2160 | 103 |
| Q3 2011 | 5,000 | 7,893.75 | 158 | 6.38 | 7,887.37 | 2100 | 2184 | 104 |
| Q4 2011 | 5,500 | 13,776.21 | 250 | 5.99 | 13,770.22 | 2100 | 2208 | 105 |
| FY 2011 Total | 15,000 | 29,903.00 | 199 | 128.78 | 29,774.22 | 8400 | 8760 | 104 |
* Number of hours a week that sequencing machines are available to produce data.
FY 2010 Summary
| Quarter | Total Bases (Billions) | Total Bases (Billions) by Platform | Operating Hours** | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Goal | Actual Total | Actual % of Goal | Sanger* | 454 | Illumina | Goal | Actual Total | Actual % Goal | |
| Q1 2010 | 275 | 640.365 | 233 | 1.223 | 45.865 | 593.278 | 2,100 | 2160 | 103 |
| Q2 2010 | 275 | 1,784.271 | 649 | 0.735 | 81.792 | 1,701.744 | 2,100 | 2160 | 103 |
| Q3 2010 | 275 | 1,609.752 | 585 | 0.974 | 108.558 | 1,500.22 | 2,100 | 2184 | 104 |
| Q4 2010 | 275 | 2,006.41 | 730 | 1.196 | 124.393 | 1,880.818 | 2,100 | 2208 | 105 |
| FY 2010 Total | 1,100 | 6,040.796 | 549 | 4.128 | 360.608 | 5,676.060 | 8,400 | 8712 | 104 |
* Q20 bases — indicates good confidence in the assignment of a base.
** Number of hours a week that sequencing machines are producing data.
FY 2009 Summary
| Quarter | Total Bases (Billions) | Total Bases (Billions) by Platform | Operating Hours** | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Goal | Actual Total | Actual % of Goal | Sanger* | 454 | Illumina | Goal | Actual Total | Actual % Goal | |
| Q1 2009 | 39.9 | 124.21 | 311 | 6.02 | 23.01 | 95.18 | 2100 | 2088 | 99.4 |
| Q2 2009 | 60.1 | 196.829 | 328 | 5.849 | 38.48 | 152.5 | 2100 | 2146 | 102 |
| Q3 2009 | 71.2 | 236.566 | 332 | 5.251 | 63.127 | 168.188 | 2100 | 2184 | 104 |
| Q4 2009 | 81.8 | 446.278 | 546 | 3.452 | 45.96 | 396.866 | 2100 | 2208 | 105 |
| FY 2009 Total | 253 | 1003.887 | 397 | 20.58 | 170.58 | 812.73 | 8400 | 8626 | 103 |
* Q20 bases — indicates good confidence in the assignment of a base.
** Number of hours a week that sequencing machines are producing data.
FY 2008 Summary
| Quarter | Total Bases (Billions) | Total Bases (Billions) by Platform | Operating Hours** | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Goal | Actual Total | Actual % of Goal | Sanger* | 454 | Illumina | Goal | Actual Total | Actual % Goal | |
| Q1 2008 | 9.8 | 7.2 | 73.40 | 4 | 3.2 | – | 2100 | 1512 | 72 |
| Q2 2008 | 10 | 9.2 | 91.19 | 2.3 | 6.9 | – | 2100 | 1800 | 85.7 |
| Q3 2008 | 11 | 41.17 | 374.27 | 5.99 | 8.28 | 26.9 | 2100 | 2184 | 104 |
| Q4 2008 | 12 | 67.94 | 566.17 | 8.04 | 22.8 | 37.1 | 2100 | 2208 | 105 |
| FY 2008 Total | 42.8 | 125.51 | 293 | 20.3 | 41.17 | 64 | 8400 | 7704 | 92 |
* Q20 bases — indicates good confidence in the assignment of a base.
** Number of hours a week that sequencing machines are producing data.
FY05-07 Sequencing Goals and Results
| Fiscal Year | Sequence (GB) | Operating Hours | ||
|---|---|---|---|---|
| Targets | Actual* | Targets | Actual | |
| 2007 | 40 | 39.22 | 8400 | 8609 |
| 2006 | 30 | 32.74 | 8400 | 8734 |
| 2005 | 28 | 33.63 | 8400 | 8760 |
* Reflects actual data due to analysis beyond fiscal year-end close.